The reason for the recall is "CGMP Deviation: Presence of dark brown discoloration on edges of tablets," USFDA said. The ongoing voluntary recall is a class II recall, the report said.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/369GI2s
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Jubilant Cadista Inc recalls 63,216 bottles of erosive esophagitis tablets
0 comments:
Post a Comment